Expert Video - What is biomarker testing and genetic testing in ovarian cancer? Why are they important?
Certain proteins and other substances are known as biomarkers because they signal the presence of cancer and reveal its type. Gynecologic oncologist Dr. Scott Richard explains how doctors test for biomarkers and genetic mutations that can signal ovarian cancer or raise the risk of developing it.
Biomarker testing can reveal different types of ovarian cancer, and this can lead to more effective treatment choices. Genetic testing, including the well-known tests for BRCA1 and BRCA2, can help you understand your risk, take steps to reduce it, or help family members with the mutations reduce their risk.
This educational activity has been developed by the National Ovarian Cancer Coalition in collaboration with Mechanisms in Medicine Inc.
This activity is supported by educational grants from: Alkermes plc, AstraZeneca Pharmaceuticals LP, Clovis Oncology, Inc., Eisai Inc., Foundation Medicine, Inc., Genentech, a Member of the Roche Group, GSK, ImmunoGen, Inc., Merck & Co, Inc., Novartis, Novocure Inc., Pfizer, Inc.
This website is part of the Animated Patient® series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.